headlines

Strategic CRO takes $100m hit from Pfizer's shelved PCSK9 candidate

Image: iStock/raphspam

Contract research organisation (CRO) ICON has taken a hit to its book-to-bill ratio after Pfizer dropped its anti-cholesterol candidate bococizumab in November.

Teewinot ups cannabinoid production capabilities

Teewinot ups cannabinoid production capabilities

HPCTC adopts biometric fingerprint tech to register patients

HPCTC adopts biometric fingerprint tech to register patients

Charles River splits off and divests CDMO business

Charles River splits off and divests CDMO business

Image: iStock/toons17

Is the return of the one-stop-shop model just a CMO marketing ploy?

iStock/wildpixel

Quotient buys QS Pharma in latest US expansion move

Graham Cotton, Senior R&D Group Leader, Almac Discovery; Tracy Robson; and Professor Tim Harrison, VP Discovery Chemistry, Almac Discovery.

Almac Discovery and RCSI enter research collaboration

PRA and Takeda establish new joint venture in Japan

PRA and Takeda establish new joint venture in Japan

Image: iStock/cacaroot

Bio-outsourcing share to drop as Big Pharma invests heavily in-house, analyst

ACRP developed CRA framework open for comment

ACRP develops framework in response to 'significant' CRA shortage

See More headlines